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Abstract
Purpose To examine whether items in Berger’s HIV Stigma Scale function differently with persons of different age, gender, 
and cultural backgrounds.
Methods Secondary data from cohorts, collected in South India (n = 250), Sweden (n = 193), and the US (n = 603) were 
reanalyzed to evaluate DIF within, between, and across these cohorts. All participants had answered the revised version of 
the HIV stigma scale consisting of 32 items forming the subscales Personalized stigma, Disclosure concerns, Concerns 
about public attitudes, and Negative self-image. Differential Item Functioning (DIF) for these items was assessed using 
hybrid ordinal regression-IRT technique. When DIF was detected, the cumulative impact of DIF on individual subscale 
scores was evaluated.
Results DIF was detected for 9 items within, between, or across cohorts, but the DIF was negligible in general. Detected DIF 
between the Swedish and Indian cohorts had a cumulative salient impact on individual scores for the subscale Disclosure 
Concerns; Disclosure concerns were overestimated in the Swedish cohort and both over- and underestimated in the Indian 
cohort.
Conclusions The items in the 32-item version of the HIV stigma scale did not seem to be particularly prone to present DIF. 
The DIF between the Indian and Swedish cohort for items in the subscale Disclosure Concerns could, however, result in 
both type I and type II errors if scores should be compared between the Indian and Swedish cohort.
Keywords HIV · Stigma · The HIV stigma scale · Differential item functioning · Item Response Theory · Psychometrics
Background
Since the beginning of the pandemic, people with HIV 
have been stigmatized. Mahajan [1] defines HIV-related 
stigma as when people living with HIV are labeled, stereo-
typed, experience separation and status loss, and become 
discriminated both on an individual and structural level. 
Across different contexts perceived HIV-related stigma is 
associated to poor mental and physical health for persons 
living with HIV [2–5]. Even in the current era of efficient 
treatment, making HIV a chronic illness with normal life 
expectancy where treatment is generally available, people 
living with HIV are exposed to and relate to HIV-related 
stigma [6, 7] and stigma has been found to be a common 
barrier to treatment and prevention [8, 9].
Stigma has sometimes been understood as an individual 
process, where stigma is constituted of what some indi-
viduals do to others [10], whereas other scholars have 
argued that an individual perspective of stigma only may 
be relevant in highly individualized countries (as the US 
or some parts of Europe) [11]. Parker and Aggleton [11] 
argue that stigma, where it appears, is strongly related 
to the specific context of culture and power, and that the 
social and cultural phenomenon of stigma may be linked 
to actions of whole groups of people. Some known aspects 
of HIV-related stigma are also clearly cultural specific, as 
they, for example, relate to specific religious beliefs [12].
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The efforts to reduce HIV-related stigma have yet not 
matched the magnitude of the problem [13]. Parker and 
Aggleton suggest that the diversity and complexity of 
HIV-related stigma makes it difficult to grasp in a pro-
grammatically useful way [11]. Ogden and Nyblade, on the 
other hand, argue that differences in HIV-related stigma 
across cultures are largely superficial and that stigma is 
expressed remarkably consistent across contexts [13]. 
Valid and reliable instruments for measuring HIV-related 
stigma are essential for stigma research, for evaluation of 
stigma-reducing interventions, and for monitoring and 
understanding experiences of HIV-related stigma [10, 14, 
15]. Based on findings that suggest consistencies in HIV-
related stigma across cultures [13], it would be valuable to 
have measures of HIV-related stigma that are valid across 
cultures, thus enabling measurement of changing trends in 
HIV-related stigma over time and across contexts.
One of the many instruments designed to measure HIV-
related stigma perceived by persons living with HIV is the 
HIV Stigma Scale by Berger et al. [16]. Although devel-
oped and originally found valid and reliable in a US con-
text [16], the instrument has been translated and found to 
be relevant and valid across various countries and cultures 
[17, 18]. These findings suggest that HIV-related stigma as 
assessed by the Berger’s scale is, to some extent, universal. 
For example, the HIV Stigma Scale has been used to com-
pare levels of perceived HIV-related stigma among persons 
living with HIV in Kenyan, Puerto Rican, and the United 
States contexts [3], where Hispanics reported significantly 
higher levels of stigma than persons from the African con-
tinent. When used in Kenya, Puerto Rico, and the United 
States, the HIV Stigma Scale showed good internal con-
sistency measured by Cronbach’s α for the combined data. 
The authors, however, did not explore differential item 
functioning for items in the HIV Stigma Scale, and it is 
possible that participants from different countries inter-
preted the items differently, resulting in bias.
Participants’ interpretation of scales can be assessed 
with methods based on Item Response Theory (IRT) and 
analysis of Differential Item Functioning (DIF). As items 
in the HIV Stigma Scale are statements that participants are 
requested to agree or disagree with on a four-point Likert 
scale, the probability that an individual will agree with the 
statement on a certain item can, according to IRT, be seen 
as a mathematical function of how stigmatized the person is 
and how severe the stigma is that the item captures. Items in 
the HIV Stigma Scale would be considered to have DIF if 
participants with different sociodemographic backgrounds 
have unequal probabilities of agreeing with statements in 
the items, while experiencing the same level of stigma [19]. 
For example, an analysis of DIF in an American sample, 
showed that black, non-Hispanic persons and white, non-
Hispanic persons with the same level of stigma, had different 
probabilities of agreeing with items in the HIV Stigma 
Scale, indicating that persons with different backgrounds 
may experience HIV-related stigma differently [20].
In addition to its use in several studies in the United 
States [21–23], the HIV Stigma Scale has been used, for 
example, in Sweden [18] and South India [17], providing 
an ideal opportunity to evaluate whether DIF occurs. The 
HIV Stigma Scale has been translated into the respective 
native languages, back translated into English, and checked 
for comparability with the original English questionnaire 
[17, 18]. The English, Tamil, and Swedish versions of the 
instrument could therefore be considered consistent regard-
ing content and all items were found relevant for both a 
Swedish and a South Indian context by both experts and 
people living with HIV in each country [17, 18]. There are, 
however, results from the psychometric validation from 
both the Swedish and the Indian contexts that may indicate 
that at least parts of the concept of HIV-related stigma are 
culturally embedded. For the Swedish version, a high rate 
of missing responses were found for an item regarding the 
risk of losing employment if one’s HIV status is disclosed, 
where written comments in the margin of the questionnaire 
(“Does this happen in Sweden?”) indicated that some Swed-
ish respondents found this item irrelevant [18]. In validation 
of the Indian version of the HIV Stigma Scale, respondents 
had difficulties understanding the four-point Likert scale 
and the word “unclean” in the item “Having HIV makes me 
feel unclean” was often misinterpreted to mean “personal 
hygiene” [17].
Although the HIV Stigma Scale has been used for meas-
uring stigma in a wide range of different contexts, it is not 
clear whether items in the HIV Stigma Scale are interpreted 
differently by persons with different backgrounds. The aim 
of the present study was, therefore, to examine whether 
items in the HIV Stigma Scale function differently with 
regard to gender and cultural background.
Method
Overview
The present work builds on secondary analysis of data col-
lected using the HIV Stigma Scale in India [17], Sweden 
[18], and three areas in the US, South Carolina [24], Iowa 
[24], and the city of Chicago [20]. Item-level data from these 
studies were used to evaluate items for DIF between, within, 
and across the cohorts. A hybrid ordinal logistic regres-
sion—IRT approach [25] was used for DIF detection, using 
the lordif-package [26] with R statistics [27]. When DIF 
was detected, we evaluated the cumulative impact that the 
detected DIF had on individual IRT scores [28].
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Data source
Data from the Swedish cohort were collected at the Karo-
linska University hospital in Stockholm in 2013 from 193 
persons living with HIV [18]. Data for the South Indian 
cohort were collected from 2007 to 2008 through networks 
caring for men and women living with HIV in the state of 
Tamil Nadu. Participants were residing in and around the 
cities Chennai (n = 150), which is an urban area and Vellore 
(n = 100), a semirural area [17]. Data from the United States 
were collected at two different time points in three different 
states. Between 2005 and 2010, data were collected through 
Ryan White II/III clinics and a community-based organiza-
tion providing medical case management in South Carolina 
(n = 210) [20], from Iowa Department of Public Health Title 
II case-managed clients in Iowa (n = 331) [20], and a private 
University Hospital HIV Clinic in Chicago (n = 62) [24].
Available data on sociodemographic information differed 
across location. Information about gender and age was avail-
able for all participants from Sweden, India, and Chicago 
(US). Gender was categorized as male, female, or transgen-
der in data collected in Chicago, with one participant catego-
rized as transgender. For all other data, gender was catego-
rized as male or female. Differences between cohorts were 
assessed with χ2-test for gender and ANOVA with Tukey 
post hoc analysis for age.
The HIV Stigma Scale
The HIV Stigma Scale is designed to measure four dimen-
sions of perceived HIV-related stigma among persons liv-
ing with HIV: Personalized stigma, Disclosure concerns, 
Concerns about public attitudes, and Negative self-image. 
Personalized stigma is proposed to capture perceived conse-
quences of other people knowing about one’s HIV infection. 
Disclosure concerns captures concerns that one can have 
over disclosing one’s HIV status to others. Concerns about 
public attitudes includes concerns that one can have over 
what other people think about people with HIV. Negative 
self-image includes negative feelings that one can have about 
oneself related to one’s HIV, (e.g., feeling unclean or not as 
good as others because of HIV) [16]. In scale construction 
of the original HIV Stigma Scale, items were assigned to 
dimensions following an exploratory factor analysis where a 
majority of items cross-loaded. Seventeen items were there-
fore assigned to more than one dimension. Subscales were 
subsequently refined to consist of unique items in a revised 
32-item version [29]. Since DIF analyses with the lordif-
package assume unidimensionality in the latent trait, where 
all items measure a single concept [19], the items that com-
pose the revised 32-item version of the HIV Stigma Scale 
were used in the present work. The instrument includes 32 
statements related to HIV stigma that are completed on a 
four-point Likert scale, ranging from 1 (“completely disa-
gree”) to 4 (“completely agree”), and item scores for each 
subscale are summed into subscale scores [16]. Higher 
scores indicate higher levels of perceived stigma for all four 
subscales.
Unidimensionality
Unidimensionality for scales was assessed through confirma-
tory factor analysis (CFA), where all items in each scale were 
specified to load onto one single factor, respectively. Since 
responses to the HIV stigma scale are ordinal, the CFA mod-
els were fitted using weighted least squares means and vari-
ance (WLSMV) [30]. Measures of model fit used were as fol-
lows: Chi-square (expected to be non-significant if the model 
showed acceptable fit to the data), the Comparative Fit Index 
and the Tucker–Lewis Index (CFI and TLI, cut-off > 0.95), 
and the root mean square error of approximation (RMSEA, 
cut-off < 0.08) [31, 32]. Since Chi-squares were significant 
in all CFA’s but three and RMSEA exceeded the cut-off for 
two subscales regarding the Swedish cohort, we also assessed 
the dimensionality of the models exploratory with parallel 
analysis and the Empirical Kaiser Criterion [33].
DIF detection
A combined ordinal logistic regression—IRT approach 
for DIF detection and analysis of DIF impact [25]—was 
employed, as implemented in the lordif-package [26]. First, 
IRT item parameter estimates were obtained, using the 
mirt package [34], according to the graded response model 
[35]. The graded response model was chosen over the par-
tial credit model since all items had the same number of 
response categories (four). Missing values were not imputed; 
participants were excluded listwise in each separate analysis 
if missing values were present. The minimum cell count for 
not collapsing response categories was set to five. Three 
ordinal regression models were examined for each item:
where P(ui ≥ k) represented probabilities that item response 
ui is k or higher [26], θ was the latent trait in the present 
work, four dimensions of perceived HIV-related stigma (Per-
sonalized stigma, Disclosure Concerns, Concerns of public 
attitudes and Negative Self-image). Group was a variable 
indicating group (country or gender) and (θ × group) rep-
resented the interaction between the latent trait and group. 
Pseudo R2 changes (Nagelkerke) were used as a criterion 
Model 1 (no DIF) ∶ logitP(ui ≥ k) = 훼k + 훽1 × 휃
Model 2 (uniform DIF) ∶ logitP(ui ≥ k) = 훼k + 훽1 × 휃 + 훽2 × group
Model 3 (non − uniform) DIF ∶ logitP(ui ≥ k)
= 훼k + 훽1 × 휃 + 훽2 × group + 훽2 × 휃 × group,
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for DIF detection. When pseudo R2 changes for an item 
exceeded the empirical threshold, that item was flagged 
for DIF. Pseudo  R2 changes between Model 1 and Model 2 
indicate a uniform DIF, with a constant effect for different 
levels of stigma while pseudo R2 changes between Model 2 
and 3 indicate a non-uniform DIF, with an effect that varied 
conditional on levels of stigma. The procedure was extended 
for multiple groups in analysis of DIF between cohorts [26]. 
Empirical thresholds for DIF detection were generated 
through Monte Carlo simulations of DIF-free samples [26]. 
The empirical thresholds were set to be above the highest 
value identified in the Monte Carlo simulation, identical for 
all items in each separate analysis, but varying between anal-
yses [26]. The Monte Carlo-simulated item-level thresholds 
are presented in Online Resource 1.
An iterative process was used to prevent false-positive 
and false-negative results that may occur when many items 
with DIF are included in analysis [25]. Trait estimates were 
updated using the items that were not flagged for DIF and 
used as a new threshold for DIF detection. The logistic 
regression was then repeated and if different items were 
flagged for DIF than in the initial calculation, trait estimates 
were updated again based on the DIF-free samples in the 
most previous round. This procedure was repeated until the 
same items were flagged for DIF in two successive rounds 
[26].
Based on the knowledge that HIV-related stigma can be 
experienced differently by persons living with HIV from 
different backgrounds [20], a series of DIF analyses was per-
formed between and within each cohort, comparing groups 
with different backgrounds. For the US cohort, DIF was 
examined between Black, non-Hispanic persons and White, 
non-Hispanic persons (data collected in Chicago excluded), 
as earlier examined by Rao et al. [20]. The US cohort was 
then combined with the Swedish and South Indian cohort 
and DIF was assessed between persons living in Sweden, 
the US, and South India. Since respondents in the different 
cohorts differed with respect to gender, we also examined 
whether the HIV Stigma Scale had DIF between men and 
women. Transgender was in analysis coded as missing since 
this category only included one respondent. DIF related to 
gender was assessed for the three cohorts combined and are 
referred to as DIF across cohorts.
Magnitude of detected DIF
There are no minimal clinically important score differences 
specified for the HIV Stigma Scale to define a salient DIF. 
We therefore evaluated the individual-level cumulative 
impact of detected DIF through comparing unadjusted IRT 
scores (with DIF) with adjusted IRT scores (accounted for 
DIF). Unadjusted IRT scores were subtracted from adjusted 
IRT scores and if individual IRT scores were unaffected by 
DIF, this difference would be zero [28]. Differences that 
were equal to or exceeded a small effect size (i.e., 0.20) were 
considered to be salient [36].
Results
Demographic characteristics
Demographic characteristics by cohort are shown in 
Table 1. The US sample had a significantly higher pro-
portion of males compared to the Indian sample (66% vs. 
50%, χ2 = 60.8, p < 0.001). Further, the one-way ANOVA 
showed a statistical significance between group effect of 
age (F(2,495) = 126.7, p < 0.001) (data on participants’ age 
were not available for Iowa and South Carolina). Post hoc 
comparisons using the Tukey HSD test indicated that the 
mean age of Indian respondents (mean = 35, SD = ± 6) was 
significantly lower than the mean age of respondents from 
the US (mean = 43, SD = ± 11) and Sweden (mean = 49, 
SD = ± 12), p < 0.001. Mean age for respondents from the 
US (mean = 43, SD = ± 11) was also significantly lower 
than the mean age of Swedish respondents (mean = 49, 
SD = ± 12), p < 0.001.
Unidimensionality
The unidimensional models yielded reasonable fit for all 
data combined and for the South Indian and US cohort 
separately (Table 2) which suggested suitability for unidi-
mensional IRT analysis. For the Swedish cohort, unidimen-
sionality was not supported in the confirmatory analysis for 
the scales Disclosure concerns and Concerns with public 
attitudes. The exploratory analysis using parallel analysis 
suggested one-factor solution in all analyses. The Empirical 
Kaiser Criterion, however, suggested two-factor solutions for 
Disclosure concerns and Negative self-image regarding the 
South Indian cohort and for Disclosure concerns regarding 
the Swedish cohort.
Fit of the graded response models
The lowest number of endorsements for a category in a 
group was six. Since the minimum cell count was set to five, 
none of the response categories were collapsed.
DIF detection
Nine items in the HIV Stigma Scale were flagged for DIF 
with pseudo R2 change exceeding the thresholds gener-
ated through Monte Carlo simulations of DIF-free samples 
(Table 3). Both uniform (with a constant effect for differ-
ent levels of stigma) and non-uniform DIF findings (with 
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an effect that varies depending on levels of stigma) were 
detected.
DIF within cohorts—the US cohort
For the US cohort, DIF was examined between Black, non-
Hispanic persons and White, non-Hispanic persons. No 
items were flagged for DIF within the US cohort.
DIF between cohorts
Nine items in the HIV Stigma Scale were flagged for either 
uniform, non-uniform, or both uniform and non-uniform DIF 
between persons living in Sweden, the US, and South India, 
respectively. One item for Personalized stigma, five items 
for Disclosure concerns, one item for Concerns about public 
attitudes, and two items for Negative self-image (Table 3).
DIF across cohorts—gender
One item was found to have non-uniform DIF between men 
and women (Table 3) (1. In many areas of my life, no one 
knows that I have HIV, belonging to the subscale Disclosure 
concerns).
Magnitude of detected DIF
The detected DIF was, in general, negligible, since the 
cumulative impact of DIF on individual IRT scores was 
below 0.2. Salient individual-level impacts of DIF (exceed-
ing 0.2) were, however, detected between cohorts for the 
subscales Disclosure concerns, which are detailed below and 
shown in Fig. 1.
DIF between cohorts—cumulative DIF impact on individual 
scores
Regarding DIF between cohorts, changes in individual IRT 
scores exceeded 0.2 and were therefore thought to be sali-
ent for the subscale Disclosure concerns (Fig. 1). Scores for 
respondents from the US were mainly unaffected by DIF, but 
DIF had a salient impact on scores for Indian and Swedish 
respondents, with effects in opposite directions. For Disclo-
sure concerns, the HIV Stigma Scale seemed to overesti-
mate scores for Swedish participants and both overestimate 
(for persons with low levels of Disclosure concerns) and 
underestimate (for persons with high levels of Disclosure 
concerns) scores for Indian participants (Fig. 1). The mean 
of the differences was close to zero, indicating that this DIF 
would not affect the mean score if levels of Disclosure con-
cerns would be presented for persons from the Swedish, US, 
and South Indian cohort together.
Discussion
The HIV Stigma Scale was developed for quantitative meas-
urement of HIV-related stigma, as perceived by persons liv-
ing with HIV. Though adapted and used in diverse contexts, 
this is the first time that the instrument has been assessed 
for gender-related DIF and DIF across different cultural con-
texts. The results of the present study indicate that the items 
in the HIV stigma scale were not especially prone to present 
culture-related DIF for the subscales Personalized stigma, 
Concerns about public attitudes, and Negative self-image. 
These subscales seem to cover aspects of stigma that in gen-
eral are equally interpreted regarding content across the dif-
ferent groups investigated. These results indicate that levels 
of Personalized stigma, Concerns about public attitudes, 
and Negative self-image may be compared between the 
cohorts without the risk of results being culturally biased. 
Salient DIF was, however, found between the South Indian 
and Swedish cohorts for the subscale Disclosure concerns. 
The subscale Disclosure concerns measures concerns that 
one can have over disclosing one’s HIV status to others. The 
items that present DIF mainly covers the aspect that one’s 
HIV is a secret and we can only speculate about potential 
reasons for this DIF. Since India is more densely populated 
than Sweden, it may be likely that participants in the South 
Indian cohort live physically closer to family and neighbors 
than the participants in the Swedish cohort, making it harder 
Table 1  Demographic characteristics of respondents to the HIV 
Stigma Scale in South India [11], Sweden [12], and the US [11, 14, 
18]
Respondents with missing values in one or more of the HIV stigma 
subscales were excluded
a Significant difference between India and the United States (χ2 = 60.8, 
p < 0.001)
b Overall significant difference (ANOVA): F(2,495) = 126.7, p < 0.001
c Significant difference between India and Sweden, Tukey post hoc 
test, p < 0.001
d Significant difference between India and Chicago, Tukey post hoc 
test, p < 0.001
e Significant difference between Chicago and Sweden, Tukey post hoc 
test, p < 0.001
f Age only available for respondents from Chicago
Cohort n Gender
%Female
Ageb
Mean, range (SD)
South India 250 50a 35, 18–49 (6)c,d
Sweden 188 43 49, 19–83 (12)c,e
The United States 598 34a 43, 23–68 (11)d,e,f
All 1036 40 41, 18–83 (11)
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for the South Indian participants to keep their HIV a secret. 
India has been characterized as a ‘collectivist’ society [37] 
and Sweden more of an individualistic society [38], particu-
larly around interpersonal issues. According to Chadda and 
Deb [37] family is far more involved in the care of its mem-
bers in the Indian society, compared to western societies. 
This might also make it more difficult for the South Indian 
participants to keep their HIV a secret from their family, 
compared to the Swedish participants. If keeping one’s HIV 
a secret is difficult, on the edge of being impossible, in the 
South Indian context, items like “I work hard to keep my 
HIV a secret” might have been perceived as irrelevant for 
South Indian participant, thus generating the detected DIF.
When Rao et al. [20] examined DIF between Black, non-
Hispanic persons and White, non-Hispanic persons, nine 
items of the scale demonstrated DIF. Our present results 
did not replicate these findings, as no items were flagged for 
DIF between Black, non-Hispanic persons and White, non-
Hispanic persons. A possible explanation for the differences 
in results could be that Rao et al. [20] examined the 40-item 
version of the HIV Stigma Scale, while the 32-item version 
was examined in the present study. Seven of the items, from 
the 40-item full version of the instrument, that demonstrated 
DIF in the earlier study by Rao et al. were items that cross-
loaded in an exploratory factor analysis and therefore were 
excluded from the 32-item version of the instrument [29].
Table 2  Assessment of unidimensionality for all subscales in the 32-item HIV Stigma Scale
Figures in bold indicate that the subscale was not unidimensional according to EKC
*p < 0.001
a Confirmatory factor analysis of unidimensional models, fitted using the weighted least squares mean and variance (WLSMV)
b The Empirical Kaiser Criterion
Subscale Fit measures from  CFAa
All data combined Indian cohort Swedish cohort US cohort
Personalized stigma
 n 960 244 157 559
 Chi-square(df = 44) 148.37* 75.0544* 67.12* 150.40*
 CFI 0.998 0.995 0.999 0.998
 TLI 0.998 0.993 0.999 0.997
 RMSEA 0.050 0.054 0.058 0.066
Disclosure concerns
 n 992 250 168 574
 Chi-square(df = 20) 134.66* 24.74, ns 51.87* 90.50*
 CFI 0.991 0.996 0.992 0.992
 TLI 0.997 0.994 0.989 0.989
 RMSEA 0.076 0.031 0.098 0.078
Concerns about public attitudes
 n 965 246 159 560
 Chi-square(df = 9) 39.48* 4.38, ns 38.38* 34.63*
 CFI 0.997 1.000 0.987 0.997
 TLI 0.995 1.008 0.979 0.995
 RMSEA 0.059 < 0.001 0.114 0.071
Negative self-image
 n 1010 248 180 582
 Chi-square(df = 14) 45.65* 35.79* 9.72, ns 38.28*
 CFI 0.997 0.981 1.000 0.996
 TLI 0.995 0.972 1.003 0.994
 RMSEA 0.047 0.079 < 0.001 0.055
Number of factors proposed to retain by  EKCb
 Personalized stigma 1 1 1 1
 Disclosure concerns 1 2 2 1
 Concerns about public attitudes 1 1 1 1
 Negative self-image 1 2 1 1
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Table 3  Differential item functioning findings for items in Berger’s HIV Stigma Scale (32-item version) within, between, and across the three 
cohorts
Items DIF within cohorts
U.S.  cohorta
DIF between  cohortsb DIF across cohorts
DIF related to  genderc
Uniform DIF Non-uniform DIF Uniform DIF Non-uniform DIF Uniform DIF Non-uniform DIF
Personalized  stigmad
 Thresholdh 0.01 0.01 0.01
  18. Some people 
who know I 
have HIV have 
grown more 
distant
0.0002 0.0002 0.0007 0.0029 0.0031 < 0.0001
  24. I have been 
hurt by how 
people reacted 
to learning I 
have HIV
0.0003 0.0004 0.0061 0.0005 0.0079 < 0.0001
  26. I regret hav-
ing told some 
people that I 
have HIV
0.0016 0.0022 0.0046 0.0003 0.0003 < 0.0001
  28. Some people 
avoid touching 
me once they 
know I have 
HIV
0.0003 0.0000 0.0077 0.0007 0.0001 < 0.0001
  29. People I care 
about stopped 
calling after 
learning I have 
HIV
0.0012 0.0011 0.0016 0.0043 0.0002 < 0.0001
  32. People don’t 
want me around 
their children 
once they know 
I have HIV
0.0001 0.0000 0.0035 0.0005 0.0001 < 0.0001
  33. People have 
physically 
backed away 
from me when 
they learn I 
have HIV
0.0000 0.0009 0.0008 0.0018 0.0000 < 0.0001
  35. I have stopped 
socializing with 
some people 
because of their 
reactions to my 
having HIV
0.0005 0.0002 0.0002 0.0000 0.0000 < 0.0001
  36. I have lost 
friends by tell-
ing them I have 
HIV
0.0018 0.0014 0.0004 0.0016 0.0012 < 0.0001
  38. People who 
know I have 
HIV tend to 
ignore my good 
points
0.0015 0.0004 0.0115h 0.0038 0.0000 < 0.0001
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Table 3  (continued)
Items DIF within cohorts
U.S.  cohorta
DIF between  cohortsb DIF across cohorts
DIF related to  genderc
Uniform DIF Non-uniform DIF Uniform DIF Non-uniform DIF Uniform DIF Non-uniform DIF
  39. People seem 
afraid of me 
once they learn 
I have HIV
0.0009 0.0014 0.0004 0.0002 0.0000 < 0.0001
Disclosure  concernse
 Thresholdh 0.02 0.01 0.01
  1. In many areas 
of my life, no 
one knows that 
I have HIV
0.0048 0.0007 0.0293i 0.0204i 0.0138h 0.0001
  4. Telling some-
one I have HIV 
is risky
0.0015 0.0000 0.0005 0.0004 0.0000 0.0011
  6. I work hard to 
keep my HIV a 
secret
0.0127 0.0010 0.0517i 0.0061 0.0011 0.0002
  17. I am very 
careful who I 
tell that I have 
HIV
0.0000 0.0093 0.0219i 0.0181i 0.0020 0.0000
  21. I never feel 
the need to hide 
the fact that I 
have HIV (R)
0.0090 0.0049 0.0242i 0.0009 0.0001 0.0025
  22. I worry that 
people may 
judge me when 
they learn I 
have HIV
0.0057 0.0013 0.0023 0.0083 0.0002 0.0000
  25. I worry that 
people who 
know I have 
HIV will tell 
others
0.0000 0.0039 0.0015 0.0012 0.0003 0.0013
  37. I have told 
people close to 
me to keep the 
fact that I have 
HIV a secret
0.0014 0.0004 0.0025 0.0191i 0.0010 0.0011
Concerns about public  attitudesf
 Thresholdh 0.01 0.01 0.01
  5. People with 
HIV lose their 
jobs when their 
employers find 
out
0.0090 0.0006 0.0188h 0.0033 < 0.0001 0.0015
  9. People with 
HIV are treated 
like outcasts
0.0024 0.0019 0.0070 0.0066 < 0.0001 0.0003
  10. Most people 
believe that a 
person who has 
HIV is dirty
0.0001 0.0014 0.0019 0.0004 < 0.0001 0.0004
Quality of Life Research 
1 3
Table 3  (continued)
Items DIF within cohorts
U.S.  cohorta
DIF between  cohortsb DIF across cohorts
DIF related to  genderc
Uniform DIF Non-uniform DIF Uniform DIF Non-uniform DIF Uniform DIF Non-uniform DIF
  14. Most people 
think that a per-
son with HIV is 
disgusting
0.0004 0.0005 0.0061 0.0006 < 0.0001 0.0000
  16. Most people 
with HIV are 
rejected when 
others find out
0.0034 0.0001 0.0017 0.0038 < 0.0001 0.0001
  20. Most people 
are uncomfort-
able around 
someone with 
HIV
0.0000 0.0048 0.0008 0.0034 < 0.0001 0.0000
Negative self-imageg
 Thresholdh 0.02 0.01 0.01
  2. I feel guilty 
because I have 
HIV
0.0032 0.0002 0.0006 0.0048 0.0003 0.0000
  3. People’s 
attitudes about 
HIV make me 
feel worse about 
myself
0.0005 0.0000 0.0174h 0.0010 0.0021 0.0006
  7. I feel I am 
not as good a 
person as others 
because I have 
HIV
0.0000 0.0000 0.0026 0.0005 0.0001 0.0009
  8. I never feel 
ashamed of hav-
ing HIV (R)
0.0001 0.0064 0.0502h 0.0056 0.0002 0.0037
  12. Having HIV 
makes me feel 
unclean
0.0015 0.0002 0.0044 0.0004 0.0003 0.0000
  15. Having HIV 
makes me feel 
like I’m a bad 
person
0.0013 0.0004 0.0044 0.0007 0.0001 0.0008
  23. Having HIV 
in my body is 
disgusting to 
me
0.0004 0.0003 0.0045 0.0032 0.0021 0.0010
Empirical thresholds for DIF detection were generated through Monte Carlo simulations of DIF-free samples
a DIF between White non-Hispanics and Black non-Hispanics (data collected in Chicago excluded)
b DIF between persons living in Sweden, US, and South India
c DIF between men and women (transgender coded as missing)
d 290 white non-hispanic and 207 Black non-Hispanic participants in within cohort analysis; 559 US, 244 South Indian, and 157 Swedish partici-
pants in between cohort analysis; 586 male and 371 female participants in analysis across cohorts
e 303 White non-Hispanic and 209 Black non-Hispanic participants in within cohort analysis; 574 US, 250 South Indian, and 168 Swedish par-
ticipants in between cohort analysis; 599 male and 390 female participants in analysis across cohorts
f 296 White non-Hispanic and 206 Black non-Hispanic participants in within cohort analysis; 560 US, 246 South Indian, and 159 Swedish par-
ticipants in between cohort analysis; 583 male and 379 female participants in analysis across cohorts
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A common reason for DIF is a lack of translation 
equivalence [19]. The item “Having HIV makes me feel 
unclean” (Item 12), for example, could not be adequately 
translated to Tamil, since no words in Tamil captured the 
intended meaning of “unclean” [17]. This was adjusted 
for by letting the questionnaire be administered by profes-
sional raters in the South Indian cohort, who assured that 
item content was understood as intended [17]. A similar 
procedure was used for the Swedish cohort where members 
of the research team also were present to answer questions 
and assist respondents with explanations of items if needed 
[18]. The item “Having HIV makes me feel unclean” (Item 
12) did not demonstrate DIF in the present analysis, but if 
the HIV Stigma Scale is used as a self-administered instru-
ment as originally intended, the detected DIF may possibly 
be even more pronounced.
Unidimensionality was assessed with both confirma-
tory and exploratory methods. Since confirmatory methods 
indicated that some subscales might not be unidimensional, 
dimensionality was examined further with both parallel anal-
ysis and the Empirical Kaiser Criterion. Parallel analysis 
[39] supported unidimensionality for all subscales across 
all cohorts, while the Empirical Kaiser Criterion suggested 
two-factor solutions for the South Indian and Swedish 
cohort. Parallel analysis is an often recommended approach 
for dimensionality assessment [39]. The HIV stigma scale 
is, however, an instrument constituted of oblique, highly 
correlated factors [16, 18], and for this specific case the 
Empirical Kaiser Criterion has been shown to outperform 
parallel analysis [33]. We therefor conclude that the sub-
scales Disclosure concerns and Negative self-image may 
be, at least, bi-factorial scales when used in the Swedish or 
South Indian context. These findings may have implications 
for the interpretation of the detected DIF, as multidimension-
ality can be mistaken for DIF [40].
There are several techniques available for DIF detection, 
and there is a lack of consensus regarding thresholds for 
detection of DIF [28]. As we used a hybrid ordinal logis-
tic regression—IRT approach, other techniques may have 
produced different results. Since statistical significance not 
necessarily implies practical significance, we used a meas-
ure of effect size (changes in pseudo R2) as a criterion for 
when DIF should be detected [19]. Different sets of rules 
have been presented for when pseudo R2 should be consid-
ered to represent DIF [19], where Zumbo [41] suggested 
that cut-offs indicating moderate and large DIF should be 
0.13 and 0.26, respectively, while the Jodoin and Gierl 
approach suggests cut-offs of 0.035 and 0.070 [42]. A cut-
off level of 0.02 has also been commonly used and these 
different cut-offs can, unsurprisingly, produce very differ-
ent numbers of items flagged for DIF [19]. In the present 
work we used Monte Carlo simulations, as implemented 
in the lordif-package [26], to generate empirical cut-offs. 
This rendered cut-offs as low as 0.01 for some analyses, 
Fig. 1  Cumulative individual-
level DIF impact for subscale 
Disclosure concerns for DIF 
between persons living in South 
India (triangles), Sweden (plus 
signs), and the US (circles). The 
boxplot to the left shows dif-
ferences in IRT score between 
using scores that ignore DIF 
and scores that account for DIF. 
In the scatterplot to the right, 
the difference scores (initial-
purified) are plotted against 
the initial scores ignoring DIF 
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Table 3  (continued)
g 308 White non-Hispanic and 212 Black non-Hispanic participants in within cohort analysis; 582 US, 248 South Indian, and 180 Swedish par-
ticipants in between cohort analysis; 606 male and 401 female participants in analysis across cohorts
h Italic values indicate pseudo R2 change for items that were flagged for DIF, but where DIF did not have a salient impact on individual scores. 
The threshold for DIF detection was generated through Monte Carlo simulations of DIF-free items
i Bold values indicate items that were flagged for DIF and where DIF had a cumulative salient impact on individual IRT scores
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which also resulted in detection of DIF that did not have 
a salient impact on individual scores. This low threshold 
for DIF detection was, however, set knowing that cultural 
DIF probably was adjusted for already in data collection 
and we sought to find patterns in present DIF that perhaps 
would have been more pronounced if questionnaires had 
been exclusively self-administered.
Limitations in the present work are that data were col-
lected at different time points with over 5 years apart and 
that data from the United States and India were not col-
lected with an intention to be representative for people living 
with HIV in the respective countries [17, 20, 24]. In those 
settings, the study populations represented a sub-set of all 
people living with HIV. The results, therefore, cannot be 
generalized to represent differences between countries. Fur-
thermore, we do not know if the results would be replicated 
if data were collected at the same locations today. A recom-
mended minimum sample size for ordinal logistic regression 
is 200 participants per group [19]. Thus, a limitation in the 
present study is the Swedish sample size of 157–180 par-
ticipants depending on subscale analyzed. In a simulation 
study, sample sizes as low as 100 per group were sufficient 
to detect large DIF but not moderate DIF [43]. It is therefore 
possible that the present study failed to detect moderate but 
practically important DIF. Further limitations were that the 
datasets differed regarding gender and age, and we did not 
have access to other sociodemographic data. It is generally 
known that HIV-related stigma is linked to stigma related to 
other attributes, which can potentiate the power of stigma-
tization [1]; groups of people who are already exposed of 
racism, homophobia, sexism, or poverty are predisposed to 
greater HIV-related stigma [1]. As we did not have access to 
data other than ratings to the HIV stigma scale and gender 
and, to some extent, age, we were not able to control for 
potentially confounding variables that may have been a true 
source of DIF. For the HIV Stigma Scale it would also be 
interesting to analyze if DIF occurs between groups of differ-
ent health statuses, e.g., persons who are virally suppressed 
or not, persons who have been living with HIV for a longer 
or shorter period of time.
Aside from these limitations, we propose that the results 
in the present work indicate that the items in the subscales 
Personalized stigma, Concerns about public attitudes, and 
Negative self-image in the HIV Stigma Scale are not espe-
cially prone to present salient DIF. However, the detected 
DIF between the Indian and Swedish cohort for the subscale 
Disclosure concerns did have a cumulative, albeit small, 
salient effect on individual IRT scores, which could result 
in both type I and type II errors if levels of Disclosure con-
cerns should be compared between the Swedish and Indian 
cohorts. The detected DIF in the subscale Disclosure con-
cerns could be a “true” differential item functioning, i.e., 
that persons from the Swedish and South Indian cohort 
respond differently to items regarding “keeping one’s HIV 
a secret” and “hiding one’s HIV,” respectively, even after 
accounting for their overall level of disclosure concerns. 
One possible explanation for this could be differences in the 
actual possibility to keep private things a secret in the Indian 
society, compared to the Swedish. An additional possible 
explanation could be that the unidimensional nature that the 
subscale Disclosure concerns seems to have in the Swedish 
and South Indian cohort may have caused a DIF due to mul-
tidimensionality. Apart from the cause of the detected DIF, 
we cannot recommend the subscales Disclosure concerns for 
comparisons between Sweden and South India.
The results in the present study, however, support the use 
of the subscales Personalized stigma, Concerns about pub-
lic attitudes, and Negative self-image for comparisons of 
levels of stigma between the cohorts investigated. As the 
HIV Stigma Scale is being used to assess stigma in a wide 
range of different countries, we encourage researchers using 
the HIV Stigma Scale to cooperate across country borders 
and examine the cross-cultural validity of the instrument 
further. This would broaden the understanding of the extent 
and forms of stigma faced by people living with HIV in dif-
ferent countries.
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